Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom.

Beijing Sannuo Jiayi Biotechnology Co., Ltd., established on 2002-05-29, Business scope includes medical technology development,Technology Promotion,technology transfer,technical consulting,Technical Services,Technical Training.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Oxford Biomedica (UK) Ltd., part of Oxford Biomedica Plc, is a company headquartered in Oxford, UK. The firm develops novel gene therapy products and treatment for cystic fibrosis.

Nihon Shokuhin Kako Co., Ltd. engages in the manufacture and sale of processed corn products. It offers food-grade materials, including starch, glycated products, and dietary fiber; industrial materials; fine chemicals, such as cyclodextrin, Japanese pharmacopoeia products, and diagnostic medical substrates; by-products comprising corn salad oils; corn steep liquor; and glue ten meals. The company was founded on July 26, 1948 and is headquartered in Tokyo, Japan.

Beijing Yibo Puhui Biotechnology Development Co., Ltd., established on 2017-11-06, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Medical Research and Experimental Development;health management(Except for medical treatment activities subject to approval).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Part of Lonza Group AG, Lonza Ltd. is a company headquartered in Basel, Switzerland, that supplies chemicals for pharmacy industry.

Chongqing Precision Biotechnology Co., Ltd. is a private company headquartered in Chongqing, China, that provides research and development biotechnology services.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are the leading manufacturer of Protein A affinity ligands, a critical component of Protein A resins that are used to separate and purify monoclonal antibody therapeutics. Our ATF (Alternating Tangential Flow) systems and our growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, we developed and market an innovative line of “ready-to-use” chromatography columns under our OPUS® and MediaScout® brands that we deliver pre-packed with our customers’ choice of resin. Repligen’s corporate headquarters are in Waltham, MA (USA) and our manufacturing facilities are located in Waltham, MA, Lund, Sweden and Weingarten, Germany.

Sementis is an Australian unlisted public biotechnology company that is using its proprietary SCV platform. The Company is using its proprietary Sementis Copenhagen Vector (SCV) platform technology to generate a portfolio of innovative vaccine candidates for the prevention of allergies and infectious diseases. SCV is a novel vector platform that uses a replication-incompetent vaccinia virus to stimulate both B-cell and T-cell immune responses. The genes for disease antigens are added to the SCV, which upon inoculation elicits a potent immune response to the disease state.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Shanghai Genechem Co., Ltd. engages in the research and development of gene therapy, cell therapy, and new gene targeting of antibody drugs. It also provides gene targeting verification, new drug development, and medical test services. The company was founded by Yue Qiong Cao on August 23, 2002 and is headquartered in Shanghai, China.

Jiangsu Saiyi Cell Technology Research Institute Co., Ltd., established on 2019-03-13, Business scope includes cell engineering,Cell Series Technology Engineering,cell therapy,Antibody,gene medicine,biomedicine,food,Health products,cosmetic,Diagnostic reagents,Technology development of medical devices,Technical Services,technical consulting,technology transfer,Technical testing;sell food,cosmetic,Health products,Daily necessities,medical instruments(Except for projects without special approval);Biological tissue storage technology services,to develop.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Aide Immunotherapy Research Institute Co., Ltd., established on 2018-08-27, Business scope includes medical technology,biotechnology development,technology transfer,technical consulting,Technical Services;drug development,Sales;for-profit medical institution;Iclass of medical devices,Laboratory Instrument Sales;Computer Network Technology Services;Expo Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Class III medical device business;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuxi Shengji Pharmaceutical Technology Co., Ltd., established on 2017-09-29, Business scope includes licensed projects:Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology promotion and application services;Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);business management;Information Consulting Service(Not including licensing information consulting services);Health Consulting Services(Does not include medical services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Part of Cellular Biomedicine Group, Inc., Shanghai Cellular Biopharmaceutical Group Ltd. is a company headquartered in China. The firm develops therapies for cancer and degenerative diseases.

OBiO Technology is providing overall solution of viral based gene therapy CRO services, and CDMO/CMO services.